Sensitivity of clinical screening for detecting developmental dysplasia of the hip: a retrospective study

Enrica Pittaluga1, Alexis Arnoux2, Sophie Merckaert2

  • 1Women, Mother and Child Department (DFME), Paediatric Unit, University Hospital Lausanne (CHUV), Lausanne, Switzerland.

Swiss Medical Weekly
|August 14, 2025
PubMed

Insights

Clinical screening for infant hip dysplasia has limited sensitivity, especially for stable cases. Universal ultrasound screening may improve early detection rates for developmental dysplasia of the hip.

Area of Science:

  • Pediatric Orthopedics
  • Diagnostic Imaging
  • Neonatal Care

Background:

  • Early detection of developmental dysplasia of the hip (DDH) in infants is critical for preventing long-term complications.
  • Clinical screening is a primary method for identifying DDH, but its diagnostic accuracy requires evaluation.
  • Tertiary care settings manage a significant number of DDH cases, offering a valuable cohort for study.

Purpose of the Study:

  • To estimate the sensitivity of clinical screening for developmental dysplasia of the hip in infants.
  • To compare the diagnostic accuracy of clinical findings against ultrasound results.
  • To stratify sensitivity by the severity of developmental dysplasia of the hip.

Main Methods:

  • Retrospective evaluation of 122 newborns (0-4 months) diagnosed with DDH.
  • Comparison of clinical examinations with hip ultrasound scans using the Graf method.
  • Calculation of sensitivity and 95% confidence intervals for clinical findings.

Main Results:

  • Overall clinical screening sensitivity for DDH was 66% (95% CI: 58-74%).
  • Sensitivity was significantly higher for unstable hips (91%) compared to stable hips (50%).
  • Diagnostic timing varied between hip stability groups.

Conclusions:

  • Clinical screening for developmental dysplasia of the hip demonstrates limited sensitivity, particularly for stable hip conditions.
  • Universal ultrasound screening is suggested to enhance early detection rates for DDH.
  • Improved diagnostic strategies are needed for stable DDH cases.
Abstract

Related Concept Videos

Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...